The Okomu Oil Palm Company has announced its audited 2025 financial results, revealing a significant surge in profitability. The company reported a pretax profit of N90.6 billion, a substantial increase from N53.5 billion in 2024. This impressive performance was fueled by a strong top-line growth, with revenue climbing 52.18% year-on-year to N198.1 billion, compared to N130.2 billion in the previous year.

Revenue generation was robust across its operations, with palm, rubber, and oil processing activities contributing N172.6 billion within Nigeria. Additionally, sales to international markets added N25.5 billion to the company's top line.

The company declared a final dividend of N15 per 50 kobo share. This dividend will be payable on May 26, 2026, to shareholders whose names are on the company's register as of the qualification date of April 27, 2026.

Key performance indicators for 2025 compared to 2024:

• Revenue: N198.1 billion, a 52.18% year-on-year increase.
• Other income: N12.5 billion in 2025, down from N15.3 billion in 2024.
• Raw materials and consumables expenses: N29.5 billion, up 30.47% year-on-year.
• Employee benefits expenses: N31.03 billion in 2025, compared to N26.1 billion in 2024.
• Pretax profit: N90.6 billion, marking a 69.26% year-on-year rise.
• Post-tax profit: N57.9 billion, an increase of 45.03% year-on-year.
• Retained earnings: N48.9 billion in 2025, compared to N53.9 billion in 2024.

Beyond customer revenue, Okomu Oil also recorded 'other income' amounting to N12.5 billion. Realized foreign exchange gains were a significant contributor, totaling N8.7 billion and accounting for 69.53% of this other income.

On the expenditure side, raw materials and consumables expenses saw a notable increase to N29.5 billion from N22.6 billion in 2024. This rise was primarily driven by plantation upkeep costs, which amounted to N10.9 billion.

Employee benefit expenses also escalated to N31 billion from N26.1 billion. Contract staff wages constituted the largest portion at N21.3 billion, reflecting increased staffing costs in line with operational expansion.

After accounting for depreciation of N21.9 billion, finance costs of N4.6 billion, other expenses of N34.7 billion, and fair value gains on biological assets of N1.7 billion, the company's pretax profit reached N90.6 billion.

Following an income tax expense of N32.6 billion, the post-tax profit was N57.9 billion, representing a 45.03% increase compared to the previous year.